Supply, Installation, Commissioning & Post-Warranty Maintenance of Flow Cytometry Instrumentation and Provision of Reagents

Key Details

Description

Cambridge University Hospitals (CUH) seeks to engage with potential suppliers via this Preliminary Market Engagement exercise to seek feedback and information to the provision of Flow Cytometry Instrumentation and Reagents to CUH. Clinical flow cytometry is currently performed within the Haematopathology and Oncology Diagnostic Service (HODS) and Immunology departments based in 2 separate locations at Addenbrookes's Hospital. 1. The HODS service is a regional specialist integrated diagnostic and follow-up service for Haematological neoplasms, serving a population of approximately 4 million. HODS perform a wide range of highly complex flow cytometry assays (8-10 colours) including those for monitoring minimal residual disease (MRD). Current workload is around 20,000 assays per year. 2. Immunology at CUH provide a routine diagnostic service of nearly 6,000 tests a year. In collaboration with Clinical and research teams across the Trust, Immunology are expanding their existing repertoire, to support diagnosis of Hemophagocytic Lymphohistiocytosis (HLH). The requirements are anticipated to include: - Provision of flow cytometry instrumentation (at least two separate flow cytometry systems will be required due to location of clinical laboratories) - Provision of reagents to support a wide range of diagnostic assays across the two services - Provision of pre-analytical automation solutions - Digital connectivity solutions including off-line analysis and integration into EPIC EPR. The Authority wishes to involve the market in discussing the following general points: - Current market and market interest in this project - Available contracting models (incl. reagent rental and lease agreement) - Currently available or novel solutions for refining the whole workflow process through pre-analytical, analytical, post analytical phases - Innovation and opportunities (for example Spectral Flow Cytometry)

Suitability